Sanjivani Paranteral Ltd Q1 FY26 results press release summary

Results press release of 12 Aug 2025, summarised by AI from the filing.

Injectables revenue grew 47.1% YoY to ₹89.9 mn while oral declined 11.1% YoY to ₹88.2 mn.

Key takeaways

1. Segment shift Injectables revenue grew 47.1% YoY to ₹89.9 mn while oral declined 11.1% YoY to ₹88.2 mn.

Original filing on BSE

Sanjivani Paranteral Ltd earnings call, investor presentation and press release summaries

• Q1 FY27: Results deck (14 Aug 2026), Results press release (14 Aug 2026)
• Q4 FY26: Earnings call (15 May 2026), Results deck (14 May 2026)
• Q3 FY26: Earnings call (16 Feb 2026), Results deck (13 Jan 2026), Results press release (16 Feb 2026)
• Q2 FY26: Earnings call (19 Nov 2025), Results deck (18 Nov 2025), Results press release (15 Nov 2025)
• Q1 FY26: Earnings call (12 Aug 2025), Results deck (12 Aug 2025), Results press release (12 Aug 2025)
• Q4 FY25: Earnings call (27 May 2025), Results press release (27 May 2025)
• Q3 FY25: Results deck (27 Feb 2025)